Quadrant Capital Group’s AtriCure ATRC Stock Holding History
Bought
Maintained
Sold
Other funds holding ATRC
HRCM
NAMI
Quadrant Capital Group's ATRC Position: Q2 2026 in Review
Quadrant Capital Group sold out of AtriCure (ATRC) in Q2 2026, closing a stake of 5,616 shares — an estimated $160K sold.
Quadrant Capital Group first reported a position in ATRC in Q4 2019 and held it in 25 quarters. The position peaked at $222K in Q4 2025. 252 funds tracked by Wall St. Rank hold ATRC as of Q2 2026.
- Quadrant Capital Group reported no remaining AtriCure position as of Q2 2026 after selling out during the quarter.
- Quadrant Capital Group sold 5,616 AtriCure shares in Q2 2026, an estimated $160K.
- Quadrant Capital Group first reported a position in AtriCure in Q4 2019 and held it in 25 quarters.
- Quadrant Capital Group's AtriCure position peaked at $222K in Q4 2025.
- 252 funds tracked by Wall St. Rank held AtriCure as of Q2 2026.
Based on Quadrant Capital Group's 13F filing for Q2 2026, filed 14 Aug 2026.